Correlation Between AN2 Therapeutics and Aileron Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both AN2 Therapeutics and Aileron Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AN2 Therapeutics and Aileron Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AN2 Therapeutics and Aileron Therapeutics, you can compare the effects of market volatilities on AN2 Therapeutics and Aileron Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AN2 Therapeutics with a short position of Aileron Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of AN2 Therapeutics and Aileron Therapeutics.

Diversification Opportunities for AN2 Therapeutics and Aileron Therapeutics

-0.29
  Correlation Coefficient

Very good diversification

The 3 months correlation between AN2 and Aileron is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding AN2 Therapeutics and Aileron Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aileron Therapeutics and AN2 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AN2 Therapeutics are associated (or correlated) with Aileron Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aileron Therapeutics has no effect on the direction of AN2 Therapeutics i.e., AN2 Therapeutics and Aileron Therapeutics go up and down completely randomly.

Pair Corralation between AN2 Therapeutics and Aileron Therapeutics

Given the investment horizon of 90 days AN2 Therapeutics is expected to generate 1.14 times more return on investment than Aileron Therapeutics. However, AN2 Therapeutics is 1.14 times more volatile than Aileron Therapeutics. It trades about 0.21 of its potential returns per unit of risk. Aileron Therapeutics is currently generating about -0.33 per unit of risk. If you would invest  107.00  in AN2 Therapeutics on August 25, 2024 and sell it today you would earn a total of  27.00  from holding AN2 Therapeutics or generate 25.23% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.65%
ValuesDaily Returns

AN2 Therapeutics  vs.  Aileron Therapeutics

 Performance 
       Timeline  
AN2 Therapeutics 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in AN2 Therapeutics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, AN2 Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
Aileron Therapeutics 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Aileron Therapeutics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very inconsistent basic indicators, Aileron Therapeutics may actually be approaching a critical reversion point that can send shares even higher in December 2024.

AN2 Therapeutics and Aileron Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with AN2 Therapeutics and Aileron Therapeutics

The main advantage of trading using opposite AN2 Therapeutics and Aileron Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AN2 Therapeutics position performs unexpectedly, Aileron Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aileron Therapeutics will offset losses from the drop in Aileron Therapeutics' long position.
The idea behind AN2 Therapeutics and Aileron Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Other Complementary Tools

Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Equity Valuation
Check real value of public entities based on technical and fundamental data
Share Portfolio
Track or share privately all of your investments from the convenience of any device
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital